BioCentury
ARTICLE | Clinical News

Cystistat purified hyaluronic acid derivative regulatory update

September 11, 2000 7:00 AM UTC

BNC received European marketing approval for Cystistat to treat radiation cystitis and cystitis caused by infections, trauma, urolithiasis, urinary retention and neoplasia. Previously, Cystistat was m...